3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
22
Lymphoma
14
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Breast Neoplasms
11
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Multiple Myeloma
9
Melanoma
9
Lymphoma, Follicular
9
Neuroblastoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Ovarian Neoplasms
7
Congenital Abnormalities
7
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Chronic-Phase
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
pegfilgrastim
9
Filgrastim
6
eflapegrastim
3
Docetaxel
3
Cyclophosphamide
3
posaconazole
1
plerixafor
1
isavuconazole
1
ceftobiprole medocaril
1
angiotensin I (1-7)
1
Vancomycin
1
Sodium Chloride
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Levofloxacin
1
Itraconazole
1
Granulocyte Colony-Stimulating Factor
1
Fluconazole
1
EC regimen
1
Daptomycin
1
Cefepime
1
Caspofungin
1
Bevacizumab
1
Algorithms
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neutropenia
×
sargramostim
×
Clear all
No trials found.